Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75M Buy
53,953
+11,213
+26% +$1.36M 0.04% 385
2026
Q1
$6.99M Buy
42,740
+2,575
+6% +$396K 0.06% 292
2025
Q4
$6.99M Buy
+40,165
New +$7.33M 0.06% 287

Other funds holding INSM

IFM Investors's INSM Position: Q2 2026 in Review

IFM Investors increased its Insmed (INSM) stake by 26% in Q2 2026, buying an estimated $1.36M and bringing the position to 53,953 shares worth $5.75M. The position accounts for 0.04% of the portfolio, ranked #385.

IFM Investors first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.99M in Q4 2025. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • IFM Investors held 53,953 shares of Insmed worth $5.75M as of Q2 2026.
  • IFM Investors bought 11,213 Insmed shares in Q2 2026, an estimated $1.36M.
  • Insmed made up 0.04% of IFM Investors's portfolio in Q2 2026, its #385 holding.
  • IFM Investors first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • IFM Investors's Insmed position peaked at $6.99M in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.